Citadel Advisors’s Diebold Nixdorf DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$649K Buy
+8,600
New +$633K ﹤0.01% 8659
2025
Q4
Sell
-5,800
Closed -$331K 12871
2025
Q3
$331K Buy
5,800
+2,100
+57% +$124K ﹤0.01% 10131
2025
Q2
$205K Sell
3,700
-41,700
-92% -$1.96M ﹤0.01% 10632
2025
Q1
$1.98M Buy
45,400
+35,800
+373% +$1.56M ﹤0.01% 5545
2024
Q4
$413K Buy
9,600
+1,400
+17% +$63.1K ﹤0.01% 8974
2024
Q3
$366K Buy
+8,200
New +$339K ﹤0.01% 8893

Other funds holding DBD

Citadel Advisors's DBD Position: Q1 2026 in Review

Citadel Advisors increased its Diebold Nixdorf (DBD) stake by 36% in Q1 2026, buying an estimated $2.18M and bringing the position to 113,071 shares worth $8.53M. The position accounts for ﹤0.01% of the portfolio, ranked #3471.

Citadel Advisors first reported a position in DBD in Q3 2023 and has held it in 9 quarters since. 201 funds tracked by Wall St. Rank hold DBD as of Q1 2026.

  • Citadel Advisors held 113,071 shares of Diebold Nixdorf worth $8.53M as of Q1 2026.
  • Citadel Advisors bought 29,652 Diebold Nixdorf shares in Q1 2026, an estimated $2.18M.
  • Diebold Nixdorf made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #3471 holding.
  • Citadel Advisors first reported a position in Diebold Nixdorf in Q3 2023 and has held it in 9 quarters since.
  • 201 funds tracked by Wall St. Rank held Diebold Nixdorf as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.